Representatives across 12 disease groups make up a council that sets clinical recommendations for oncology care and those decisions are being pushed out in the electronic medical record for decision support at the point of care, said Jeffrey Patton, MD, CEO, OneOncology, and executive chairman of the board, Tennessee Oncology. Patton will lead off OneOncology's Physician Leadership Conference, which runs November 11-13 in Nashville.
Representatives across 12 disease groups make up a council that sets clinical recommendations for oncology care and those decisions are being pushed out in the electronic medical record for decision support at the point of care, said Jeffrey Patton, MD, CEO, OneOncology, and executive chairman of the board, Tennessee Oncology. Patton will lead off OneOncology's Physician Leadership Conference, which runs November 11-13 in Nashville.
Transcript
What is the role of disease groups in the OneOncology clinical pathways program? How do member practices of OneOncology work with these clinical pathways day to day?
At OneOncology, we have a clinical leadership forum called One Council—everything's “one” with us. One Council is really a Senate-based model where we have representatives from each practice make clinical decisions and clinical recommendations. Within that group, we have 12 disease groups, where we have thought leaders or folks interested in specific disease discuss and set our standard of care in those disease groups. And then we're developing a pathway to tool with Flatiron Health and called Flatiron Assist, where those recommendations are written into the electronic medical record, so you don't have to go outside of the electronic medical record to get that decision support tool. And it really is decision support at the point of care.
Collaborative Care Model Offers Success in Reducing Suicide Risk, New Report Finds
April 10th 2025A report published today by the American Foundation for Suicide Prevention underscores the potential of the collaborative care model to lower suicide risk across diverse patient populations and health systems.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Sociodemographic Factors Impact Cytoreductive Surgery Decisions in Advanced Ovarian Cancer
April 9th 2025Patients with advanced epithelial ovarian cancer who were non-Hispanic Black, older, had lower household income, resided in nonmetropolitan areas, and were unmarried had higher odds of refusing cytoreductive surgery.
Read More